Economic analysis shows point-of-care hepatitis C virus testing is cost-effective for high-risk populations, indicating a key role in HCV elimination efforts.
In this economic analysis of HCV testing strategies, a POC HCV RNA-first approach was found to be cost-effective and clinically optimal for high-risk populations, and may represent a critical component of HCV elimination efforts in the US.
No takes yet. Share an insight, caveat, or question.
Rawashdh et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: